Trends in nurse-administered procedural sedation and analgesia across cardiac catheterisation laboratories in Australia and New Zealand: Results of an electronic survey

被引：19
作者：
Conway, Aaron [1 ,2 ]
Rolley, John [3 ]
Page, Karen
Fulbrook, Paul [4 ,5 ]
机构：
[1] Australian Catholic Univ, Sch Nursing Midwifery & Paramed QLD, Sydney, NSW 2059, Australia
[2] Wesley Hosp, Auchenflower, Qld, Australia
[3] St Vincents Hosp, Cardiol Invest Unit, Melbourne, Vic, Australia
[4] Australian Catholic Univ, Sch Nursing Midwifery & Paramed QLD, Natl Ctr Clin Outcomes Res, Sydney, NSW 2059, Australia
[5] Prince Charles Hosp, Nursing Res & Practice Dev Unit, Brisbane, Qld, Australia
来源：
AUSTRALIAN CRITICAL CARE | 2014年 / 27卷 / 01期
关键词：
Conscious sedation; Deep sedation; Heart catheterisation; Artificial cardiac pacing; Cardiac electrophysiology; CARDIOVERTER-DEFIBRILLATOR; PROPOFOL SEDATION; DEEP SEDATION; ANESTHESIA; IMPLANTATION; SAFETY;
D O I：
10.1016/j.aucc.2013.05.003
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Background: Knowledge of current trends in nurse-administered procedural sedation and analgesia (PSA) in the cardiac catheterisation laboratory (CCL) may provide important insights into how to improve safety and effectiveness of this practice. Objective: To characterise current practice as well as education and competency standards regarding nurse-administered PSA in Australian and New Zealand CCLs. Design: A quantitative, cross-sectional, descriptive survey design was used. Methods: Data were collected using a web-based questionnaire on practice, educational standards and protocols related to nurse-administered PSA. Descriptive statistics were used to analyse data. Results: A sample of 62 nurses, each from a different CCL, completed a questionnaire that focused on PSA practice. Over half of the estimated total number of CCLs in Australia and New Zealand was represented. Nurse-administered PSA was used in 94% (n = 58) of respondents CCLs. All respondents indicated that benzodiazepines, opioids or a combination of both is used for PSA (n = 58). One respondent indicated that propofol was also used. 20% (n = 12) indicated that deep sedation is purposefully induced for defibrillation threshold testing and cardioversion without a second medical practitioner present. Sedation monitoring practices vary considerably between institutions. 31% (n = 18) indicated that comprehensive education about PSA is provided. 45% (n = 26) indicated that nurses who administer PSA should undergo competency assessment. Conclusion: By characterising nurse-administered PSA in Australian and New Zealand CCLs, a baseline for future studies has been established. Areas of particular importance to improve include protocols for patient monitoring and comprehensive PSA education for CCL nurses in Australia and New Zealand. (C) 2013 Australian College of Critical Care Nurses Ltd. Published by Elsevier Australia (a division of Reed International Books Australia Pty Ltd). All rights reserved.
引用
收藏
页码：4 / 10
页数：7
相关论文
共 28 条
[1]  
[Anonymous], 2006, ANMC CODE PROFESSION
[2]  
[Anonymous], 2012, NCNZ CODE CONDUCT NU
[3]  
[Anonymous], 2006, NHMRC ETHICAL CONDUC
[4]  
ANZCA, 2010, GUID SED AN DIAGN IN
[5]  
Blayney MR, 2012, CONTINUING ED ANAEST, V12, P176
[6]   Nurse-administered procedural sedation and analgesia in the cardiac catheter laboratory: An integrative review [J].
Conway, Aaron ;
Page, Karen ;
Rolley, John X. ;
Worrall-Carter, Linda .
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2011, 48 (08) :1012-1023
[7]  
COPE, COPE REP 2003
[8]   Propofol: a safe drug for physician-led procedures? [J].
de Bono, Joseph .
EUROPACE, 2012, 14 (03) :303-305
[9]  
Dillman D.A., 2009, Internet, Mail, and Mix-Mode Surveys: The Taylored Design Method
[10]  
Fox DJ, 2007, PACE, V30, P992, DOI 10.1111/j.1540-8159.2007.00797.x
123